Companies: 10,795·Total market cap: $144.5T
Azitra, Inc.

Azitra, Inc.

AZTRAMEXHealthcare● Active
$0.20
$-0.01(-3.24%)
Market Cap$2193787
P/E Ratio
52W High$2.4
52W Low$0.1
Overview

Azitra, Inc. (AZTR) PE Ratio — Current & Historical Data

Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.

aztr · pe ratio · data through Dec 31, 2025

Core PE Ratio Metrics

Trailing 12 months · TTM

The price-to-earnings (P/E) ratio for Azitra, Inc. (AZTR) measures how much investors pay for each dollar of the company's trailing earnings. AZTR's current PE ratio of N/A is calculated by dividing its stock price of $0.20 by its TTM earnings per share of -$0.76.

N/A
P/E Ratio (TTM)N/A — Company is not profitable (TTM)

Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31

Forward P/E
N/A
FY2027 est. EPS $-0.10
Based on 1 analyst
EPS (TTM)
-$0.76
TTM · diluted EPS
PEG Ratio
0.00
Below 1.0 · Growth adjusted
Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Azitra, Inc. SEC 10-K & 10-Q filings · US GAAPUpdated: 2026-06-09

PE Ratio History

2021 – 2025 · Annual
PE Ratio (TTM)
EPS (Annual)

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)

PE Ratio vs Peers

Biotechnology · 6 peers · Annual PE
CompanyMarket CapPE (Annual)vs AvgEPS (TTM)
Azitra, Inc.
Azitra, Inc.You
AZTR
$2MN/A-$0.76
Enveric Biosciences, Inc.
Enveric Biosciences, Inc.
ENVB
$1MN/A-$36.24
Indaptus Therapeutics, Inc.
Indaptus Therapeutics, Inc.
INDP
$4MN/A-$21.58
Jasper Therapeutics, Inc.
Jasper Therapeutics, Inc.
JSPR
$8MN/A-$3.95
Lipella Pharmaceuticals Inc.
Lipella Pharmaceuticals Inc.
LIPO
$0MN/A-$4.79
Onconetix, Inc.
Onconetix, Inc.
ONCO
$0MN/A-$4.28
Revelation Biosciences, Inc.
Revelation Biosciences, Inc.
REVB
$4MN/A-$14.36

* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio

Annual PE Ratio History

Showing 5 of 5 years
Fiscal Year EndPE RatioEPS (TTM)YoY ChangePE vs Max
2025-12-31Latest
FY2025
$-2.25
2024-12-31
FY2024
$-15.80
2023-12-31
FY2023
$-326.93
2022-12-31
FY2022
$-176.56
2021-12-31
FY2021
$-147.78

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API

About PE Ratio & Methodology

The price-to-earnings (P/E) ratio for Azitra, Inc. (AZTR) measures how much investors pay for each dollar of the company's trailing earnings. AZTR's current PE ratio of N/A is calculated by dividing its stock price of $0.20 by its TTM earnings per share of -$0.76.

PE Ratio = Stock Price ÷ EPS (TTM)
= $0.20 ÷ -$0.76 = N/A
TTMTrailing Twelve Months — sum of the most recent 4 quarterly EPS figures
Forward PEStock price ÷ analyst consensus EPS estimate for the next fiscal year
PEGPE ÷ earnings growth rate — values below 1.0 suggest growth may justify the premium
Figures tie to SEC 10-K/10-Q and FMP ratio endpoints where noted.

Frequently asked questions

AZTR pe ratio · 6 questions

AZTR's current PE ratio is N/A as of 2026-06-09, based on a stock price of $0.20 and TTM EPS of -$0.76. Data sourced from Financial Modeling Prep via AZTR's SEC 10-K and 10-Q filings.

AZTR PE ratioWhat is AZTR PE ratioCurrent PE ratio of AZTRAZTR PE ratio today

Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Azitra, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09